BA vs SYRE · P/E 89, rev $24.56B vs $7.60B cap
The Boeing Company (BA) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported BA revenue for 2026-06-30 was $24.56B. Net income was -$444.0M. Revenue was up 10.5% from 2026-03-31 to 2026-06-30. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
BA currently screens at market cap $177.86B and trailing P/E 89.2. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the BA and SYRE stock pages for the full models.
Not investment advice.